146 related articles for article (PubMed ID: 26292327)
1. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
Ngo N; Henthorn KS; Cisneros MI; Cubitt B; Iwasaki M; de la Torre JC; Lama J
J Virol; 2015 Nov; 89(21):10924-33. PubMed ID: 26292327
[TBL] [Abstract][Full Text] [Related]
2. Lymphocytic choriomeningitis arenavirus requires cellular COPI and AP-4 complexes for efficient virion production.
Byford O; Shaw AB; Tse HN; Todd EJAA; Álvarez-Rodríguez B; Hewson R; Fontana J; Barr JN
J Virol; 2024 Mar; 98(3):e0200623. PubMed ID: 38334330
[TBL] [Abstract][Full Text] [Related]
3. Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses.
Iwasaki M; Minder P; Caì Y; Kuhn JH; Yates JR; Torbett BE; de la Torre JC
PLoS Pathog; 2018 Feb; 14(2):e1006892. PubMed ID: 29462184
[TBL] [Abstract][Full Text] [Related]
4. Reverse genetics approaches to combat pathogenic arenaviruses.
de la Torre JC
Antiviral Res; 2008 Dec; 80(3):239-50. PubMed ID: 18782590
[TBL] [Abstract][Full Text] [Related]
5. Generation of Bi-Reporter-Expressing Tri-Segmented Arenavirus.
Ye C; Martinez-Sobrido L
Methods Mol Biol; 2022; 2524():223-233. PubMed ID: 35821475
[TBL] [Abstract][Full Text] [Related]
6. Reverse Genetics Approaches to Control Arenavirus.
Martínez-Sobrido L; Cheng BY; de la Torre JC
Methods Mol Biol; 2016; 1403():313-51. PubMed ID: 27076139
[TBL] [Abstract][Full Text] [Related]
7. Arenavirus Quasispecies and Their Biological Implications.
Grande-Pérez A; Martin V; Moreno H; de la Torre JC
Curr Top Microbiol Immunol; 2016; 392():231-76. PubMed ID: 26472215
[TBL] [Abstract][Full Text] [Related]
8. Ribavirin can be mutagenic for arenaviruses.
Moreno H; Gallego I; Sevilla N; de la Torre JC; Domingo E; Martín V
J Virol; 2011 Jul; 85(14):7246-55. PubMed ID: 21561907
[TBL] [Abstract][Full Text] [Related]
9. Identification of a clinical compound losmapimod that blocks Lassa virus entry.
Zhang X; Yan F; Tang K; Chen Q; Guo J; Zhu W; He S; Banadyga L; Qiu X; Guo Y
Antiviral Res; 2019 Jul; 167():68-77. PubMed ID: 30953674
[TBL] [Abstract][Full Text] [Related]
10. Cellular endosomal potassium ion flux regulates arenavirus uncoating during virus entry.
Shaw AB; Tse HN; Byford O; Plahe G; Moon-Walker A; Hover SE; Saphire EO; Whelan SPJ; Mankouri J; Fontana J; Barr JN
mBio; 2024 Jun; ():e0168423. PubMed ID: 38874413
[TBL] [Abstract][Full Text] [Related]
11. PDIA4 Is a Host Factor Important for Lymphocytic Choriomeningitis Virus Infection.
Xu M; Xu H; Wan W; Jian X; Jin R; Wang L; Wang J; Xiao G; Zhang L; Chen H; Wen Y
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140584
[TBL] [Abstract][Full Text] [Related]
12. Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation.
Lukashevich IS; Tikhonov I; Rodas JD; Zapata JC; Yang Y; Djavani M; Salvato MS
J Virol; 2003 Feb; 77(3):1727-37. PubMed ID: 12525606
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the type I interferon antiviral response during arenavirus infection.
Borrow P; Martínez-Sobrido L; de la Torre JC
Viruses; 2010 Nov; 2(11):2443-80. PubMed ID: 21994626
[TBL] [Abstract][Full Text] [Related]
14. Structure of the LCMV nucleoprotein provides a template for understanding arenavirus replication and immunosuppression.
West BR; Hastie KM; Saphire EO
Acta Crystallogr D Biol Crystallogr; 2014 Jun; 70(Pt 6):1764-9. PubMed ID: 24914986
[TBL] [Abstract][Full Text] [Related]
15. Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression.
Kalkavan H; Sharma P; Kasper S; Helfrich I; Pandyra AA; Gassa A; Virchow I; Flatz L; Brandenburg T; Namineni S; Heikenwalder M; Höchst B; Knolle PA; Wollmann G; von Laer D; Drexler I; Rathbun J; Cannon PM; Scheu S; Bauer J; Chauhan J; Häussinger D; Willimsky G; Löhning M; Schadendorf D; Brandau S; Schuler M; Lang PA; Lang KS
Nat Commun; 2017 Mar; 8():14447. PubMed ID: 28248314
[TBL] [Abstract][Full Text] [Related]
16. Cell surface molecules involved in infection mediated by lymphocytic choriomeningitis virus glycoprotein.
Shimojima M; Kawaoka Y
J Vet Med Sci; 2012 Oct; 74(10):1363-6. PubMed ID: 22673088
[TBL] [Abstract][Full Text] [Related]
17. The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2.
Ngwe Tun MM; Morita K; Ishikawa T; Urata S
Viruses; 2021 Jun; 13(7):. PubMed ID: 34202565
[TBL] [Abstract][Full Text] [Related]
18. Entry inhibitors as arenavirus antivirals.
Iyer K; Yan Z; Ross SR
Front Microbiol; 2024; 15():1382953. PubMed ID: 38650890
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for antibody-mediated neutralization of lymphocytic choriomeningitis virus.
Moon-Walker A; Zhang Z; Zyla DS; Buck TK; Li H; Diaz Avalos R; Schendel SL; Hastie KM; Crotty S; Saphire EO
Cell Chem Biol; 2023 Apr; 30(4):403-411.e4. PubMed ID: 36990092
[TBL] [Abstract][Full Text] [Related]
20. Suppression of viral infectivity through lethal defection.
Grande-Pérez A; Lázaro E; Lowenstein P; Domingo E; Manrubia SC
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4448-52. PubMed ID: 15767582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
